569
Views
31
CrossRef citations to date
0
Altmetric
Research Article

VEGF PROMOTER HAPLOTYPE AND AMYOTROPHIC LATERAL SCLEROSIS (ALS)

, , , , , & show all
Pages 429-434 | Published online: 11 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Caroline Moreau, Véronique Brunaud-Danel, Jean Dallongeville, Alain Duhamel, Laurence Laurier-Grymonprez, Jacques de Reuck, Anne Charlotte Wiart, Thierry Perez, Florence Richard, Philippe Amouyel, Régis Bordet, Luc Defebvre, Alain Destée & David Devos. (2012) Modifying effect of arterial hypertension on amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis 13:2, pages 194-201.
Read now
Hiroko Kishikawa, David Wu & Guo-fu Hu. (2008) Targeting angiogenin in therapy of amyotropic lateral sclerosis. Expert Opinion on Therapeutic Targets 12:10, pages 1229-1242.
Read now
Yingshuang Zhang, Huagang Zhang, Yu Fu, Hongsong Song, Liping Wang, Jun Zhang & Dongsheng Fan. (2006) VEGF C2578A polymorphism does not contribute to amyotrophic lateral sclerosis susceptibility in sporadic Chinese patients. Amyotrophic Lateral Sclerosis 7:2, pages 119-122.
Read now

Articles from other publishers (28)

J. Jiménez-Villegas, L. Ferraiuolo, R.J. Mead, P.J. Shaw, A. Cuadrado & A.I. Rojo. (2021) NRF2 as a therapeutic opportunity to impact in the molecular roadmap of ALS. Free Radical Biology and Medicine 173, pages 125-141.
Crossref
Alba Coraini, Cinzia Tiloca, Antonia Ratti, Giuliano Michelozzi, Luca Maderna & Vincenzo Silani. (2020) Cervical transverse MRI in ALS diagnosis and possible link to VEGF and MMP9 single nucleotide polymorphisms. Case Report. SN Comprehensive Clinical Medicine 2:6, pages 814-816.
Crossref
Ming-Dong Wang, Julian Little, James Gomes, Neil R. Cashman & Daniel Krewski. (2017) Identification of risk factors associated with onset and progression of amyotrophic lateral sclerosis using systematic review and meta-analysis. NeuroToxicology 61, pages 101-130.
Crossref
Yubin Wu, Yingying Zhang, Xun Han, Xiaoyuan Li, Li Xue & Anmu Xie. (2016) Association of VEGF gene polymorphisms with sporadic Parkinson’s disease in Chinese Han population. Neurological Sciences 37:12, pages 1923-1929.
Crossref
Liru YanQuanzhi GeChunyan XiXuna ZhangYujie Guo. (2015) Genetic Variations of VEGF Gene Were Associated with Tetralogy of Fallot Risk in a Chinese Han Population . Genetic Testing and Molecular Biomarkers 19:5, pages 264-271.
Crossref
Orion P. KeiferJr.Jr., Deirdre M. O'Connor & Nicholas M. Boulis. (2014) Gene and protein therapies utilizing VEGF for ALS. Pharmacology & Therapeutics 141:3, pages 261-271.
Crossref
Ana Catarina Pronto-Laborinho, Susana Pinto & Mamede de Carvalho. (2014) Roles of Vascular Endothelial Growth Factor in Amyotrophic Lateral Sclerosis. BioMed Research International 2014, pages 1-24.
Crossref
Ebru Mihci, Sibel S. Ozkaynak, Nilgun Sallakci, Ferah Kizilay & Ugur Yavuzer. (2011) VEGF polymorphisms and serum VEGF levels in Parkinson's disease. Neuroscience Letters 494:1, pages 1-5.
Crossref
Joong-Seok Kim, Sung-Vin Yim, In Song Koh, Jin Soo Choi, Ji-Yeon Yoo, Kwang-Soo Lee, Young Lim & Kweon-Haeng Lee. (2009) Single-nucleotide polymorphisms (SNPs) and haplotype analysis in vascular endothelial growth factor (VEGF) gene in the patients with Parkinson disease and lung cancer. Archives of Gerontology and Geriatrics 48:3, pages 287-290.
Crossref
Carmen Ruiz de Almodovar, Diether Lambrechts, Massimiliano Mazzone & Peter Carmeliet. (2009) Role and Therapeutic Potential of VEGF in the Nervous System. Physiological Reviews 89:2, pages 607-648.
Crossref
Sivakumar Sathasivam. (2008) VEGF and ALS. Neuroscience Research 62:2, pages 71-77.
Crossref
Gregory A. Cary & Albert R. La Spada. (2008) Androgen Receptor Function in Motor Neuron Survival and Degeneration. Physical Medicine and Rehabilitation Clinics of North America 19:3, pages 479-494.
Crossref
Mauro CozzolinoAlberto FerriMaria Teresa Carrì. (2008) Amyotrophic Lateral Sclerosis: From Current Developments in the Laboratory to Clinical Implications. Antioxidants & Redox Signaling 10:3, pages 405-444.
Crossref
Silke Schmidt, Kelli D. Allen, Valerie T. Loiacono, Barbara Norman, Catherine L. Stanwyck, Kristina M. Nord, Christina D. Williams, Edward J. Kasarskis, Freya Kamel, Valerie McGuire, Lorene M. Nelson & Eugene Z. Oddone. (2008) Genes and Environmental Exposures in Veterans with Amyotrophic Lateral Sclerosis: The GENEVA Study. Neuroepidemiology 30:3, pages 191-204.
Crossref
N. Just, C. Moreau, P. Lassalle, P. Gosset, T. Perez, V. Brunaud-Danel, B. Wallaert, A. Destée, L. Defebvre, A.B. Tonnel & D. Devos. (2007) High erythropoietin and low vascular endothelial growth factor levels in cerebrospinal fluid from hypoxemic ALS patients suggest an abnormal response to hypoxia. Neuromuscular Disorders 17:2, pages 169-173.
Crossref
Jean-Pierre Julien & Jasna Kriz. 2007. Motor neuron disorders and related diseases. Motor neuron disorders and related diseases 121 138 .
D. Bozyczko-Coyne & M. Williams. 2007. Comprehensive Medicinal Chemistry II. Comprehensive Medicinal Chemistry II 193 228 .
Claire L. Simpson & Ammar Al-Chalabi. (2006) Amyotrophic lateral sclerosis as a complex genetic disease. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1762:11-12, pages 973-985.
Crossref
Mamatha S. Nayak, Yun-Sook Kim, Michelle Goldman, Hans S. Keirstead & Douglas A. Kerr. (2006) Cellular therapies in motor neuron diseases. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1762:11-12, pages 1128-1138.
Crossref
Diether Lambrechts & Peter Carmeliet. (2006) VEGF at the neurovascular interface: Therapeutic implications for motor neuron disease. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1762:11-12, pages 1109-1121.
Crossref
Jean-Pierre Julien & Jasna Kriz. (2006) Transgenic mouse models of amyotrophic lateral sclerosis. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1762:11-12, pages 1013-1024.
Crossref
Francois Gros-Louis, Claudia Gaspar & Guy A. Rouleau. (2006) Genetics of familial and sporadic amyotrophic lateral sclerosis. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1762:11-12, pages 956-972.
Crossref
Séverine Boillée, Christine Vande Velde & Don W. Cleveland. (2006) ALS: A Disease of Motor Neurons and Their Nonneuronal Neighbors. Neuron 52:1, pages 39-59.
Crossref
Elke Bogaert, Philip Van Damme, Ludo Van Den Bosch & Wim Robberecht. (2006) Vascular endothelial growth factor in amyotrophic lateral sclerosis and other neurodegenerative diseases. Muscle & Nerve 34:4, pages 391-405.
Crossref
Diether Lambrechts, Peggy Lafuste, Peter Carmeliet & Edward M. Conway. (2006) Another angiogenic gene linked to amyotrophic lateral sclerosis. Trends in Molecular Medicine 12:8, pages 345-347.
Crossref
Younyoung Kim, Yu Jin Nam & Chaeyoung Lee. (2006) Haplotype analysis of single nucleotide polymorphisms inVEGF gene for vascular dementia. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 141B:4, pages 332-335.
Crossref
Diether Lambrechts & Peter Carmeliet. 2006. Gene Therapy of the Central Nervous System. Gene Therapy of the Central Nervous System 239 252 .
J. A. Rocha, C. Reis, F. Simões, J. Fonseca & J. Mendes Ribeiro. (2005) Diagnostic investigation and multidisciplinary management in motor neuron disease. Journal of Neurology 252:12, pages 1435-1447.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.